Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 56:328-336, 2007
DOI: 10.2337/db06-1275
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masia, R.
Right arrow Articles by Barbetti, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masia, R.
Right arrow Articles by Barbetti, F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

An ATP-Binding Mutation (G334D) in KCNJ11 Is Associated With a Sulfonylurea-Insensitive Form of Developmental Delay, Epilepsy, and Neonatal Diabetes

Ricard Masia1, Joseph C. Koster1, Stefano Tumini2, Francesco Chiarelli2, Carlo Colombo3, Colin G. Nichols1, and Fabrizio Barbetti3,4,5

1 Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri
2 Department of Pediatrics, University of Chieti, Chieti, Italy
3 Bambino Gesù Children’s Hospital IRCCS, Piazza S Onofrio 4, 00164 Rome, Italy
4 S. Raffaele Scientific Park Foundation, Rome, Italy
5 Department of Internal Medicine, University of Tor Vergata, Rome, Italy

Address correspondence and reprint requests to C.G. Nichols, Department of Cell Biology and Physiology, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110. E-mail: cnichols{at}wustl.edu. Or to F. Barbetti, S. Raffaele Scientific Park Foundation, Room B303, Via di Castelromano, 100, 00128, Rome, Italy. E-mail: fabrizio.barbetti{at}spr-r.it

Abbreviations: DEND, developmental delay, epilepsy, and neonatal diabetes; KATP channel, ATP-sensitive K+ channel; NDM, neonatal diabetes mellitus; PNDM, permanent NDM

Mutations in the pancreatic ATP-sensitive K+ channel (KATP channel) cause permanent neonatal diabetes mellitus (PNDM) in humans. All of the KATP channel mutations examined result in decreased ATP inhibition, which in turn is predicted to suppress insulin secretion. Here we describe a patient with severe PNDM, which includes developmental delay and epilepsy, in addition to neonatal diabetes (developmental delay, epilepsy, and neonatal diabetes [DEND]), due to a G334D mutation in the Kir6.2 subunit of KATP channel. The patient was wholly unresponsive to sulfonylurea therapy (up to 1.14 mg · kg–1 · day–1) and remained insulin dependent. Consistent with the putative role of G334 as an ATP-binding residue, reconstituted homomeric and mixed WT+G334D channels exhibit absent or reduced ATP sensitivity but normal gating behavior in the absence of ATP. In disagreement with the sulfonylurea insensitivity of the affected patient, the G334D mutation has no effect on the sulfonylurea inhibition of reconstituted channels in excised patches. However, in macroscopic rubidium-efflux assays in intact cells, reconstituted mutant channels do exhibit a decreased, but still present, sulfonylurea response. The results demonstrate that ATP-binding site mutations can indeed cause DEND and suggest the possibility that sulfonylurea insensitivity of such patients may be a secondary reflection of the presence of DEND rather than a simple reflection of the underlying molecular basis.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
P. Tammaro and F. M. Ashcroft
A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit
J. Physiol., November 1, 2007; 584(3): 743 - 753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. M. Ashcroft
ATP-sensitive K+ channels and disease: from molecule to malady
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E880 - E889.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Shimomura, F. Horster, H. de Wet, S. E. Flanagan, S. Ellard, A. T. Hattersley, N. I. Wolf, F. Ashcroft, and F. Ebinger
A novel mutation causing DEND syndrome: A treatable channelopathy of pancreas and brain
Neurology, September 25, 2007; 69(13): 1342 - 1349.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Masia, D. D. De Leon, C. MacMullen, H. McKnight, C. A. Stanley, and C. G. Nichols
A Mutation in the TMD0-L0 Region of Sulfonylurea Receptor-1 (L225P) Causes Permanent Neonatal Diabetes Mellitus (PNDM)
Diabetes, May 1, 2007; 56(5): 1357 - 1362.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.